Performance and Safety of a New Medical Device (Polybactum) for Reducing the Recurrence Rate of Bacterial Vaginosis: Protocol for a Multicenter, Open-Label, Noncontrolled International Clinical Trial (POLARIS Study)
BackgroundThe medical literature has reported that recurrent bacterial vaginosis (RBV) has a relapse rate of 35% within 3 months and 60% within 12 months after antibiotic administration. Products that are able to provide a barrier effect against the biofilm produced by Gardne...
Main Authors: | Filippo Murina, Paolo Inghirami, Marius Biriș, Daniela Sîrbu, Dionisio Franco Barattini, Federica Sbrocca, Luca Ivan Ardolino, Mario Mangrella, Elena Casolati, Serban Roșu, Ciprian Doru Crișan |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2023-07-01
|
Series: | JMIR Research Protocols |
Online Access: | https://www.researchprotocols.org/2023/1/e42787 |
Similar Items
-
Survey of noncontrolled medication misuse patterns
by: Amelia Slane, PharmD, et al.
Published: (2022-06-01) -
MAGNETIC FIELD OF POLARIS
by: I. A. Usenko, et al.
Published: (2010-12-01) -
P16 SOF/VEL/VOX for 8 or 12 weeks results in high SVR12 rates: an integrated analysis of the POLARIS-1, POLARIS-2, POLARIS-3 AND POLARIS-4 studies
by: Stuart K. Roberts, et al.
Published: (2017-08-01) -
IS POLARIS LEAVING THE CEPHEID INSTABILITY STRIP?
by: D. G. Turner
Published: (2017-04-01) -
STELLAR INVESTIGATION IN THE OPEN CLUSTER OF POLARIS
by: I. A. Usenko, et al.
Published: (2008-12-01)